Mostrar o rexistro simple do ítem

dc.contributor.authorFernández-Canosa, Sara
dc.contributor.authorBrocalero-Camacho, Ángela
dc.contributor.authorMartínez-Medina, Alicia
dc.contributor.authorDíez-Rodríguez, Eva
dc.contributor.authorArias, Pablo
dc.contributor.authorOliviero, Antonio
dc.contributor.authorSoto-León, Vanesa
dc.date.accessioned2024-05-27T08:42:11Z
dc.date.available2024-05-27T08:42:11Z
dc.date.issued2024-02-27
dc.identifier.citationFernández-Canosa S, Brocalero-Camacho A, Martínez-Medina A, Díez-Rodríguez E, Arias P, Oliviero A, Soto-León V. Fatigue insights from walking tests in spinal cord injury and multiple sclerosis individuals. Sci Rep. 2024 Feb 27;14(1):4761.es_ES
dc.identifier.issn2045-2322
dc.identifier.urihttp://hdl.handle.net/2183/36644
dc.description.abstract[Abstract] In the last decade, fatigue in clinical populations has been re-conceptualized, including dimensions such as perceived fatigue (trait and state fatigue) and fatigability. The aim of this study was to evaluate different expressions of fatigue in Spinal Cord Injury (SCI) and Multiple Sclerosis (MS) participants compared to able-bodied controls, during activities of daily living, especially during gait. A total of 67 participants were included in this study (23 with SCI, 23 with MS, and 21 able-bodied controls). All participants performed two functional tests (6-Minute Walk Test and 10-Meter Walk Test) and they completed the Fatigue Severity Scale (FSS). The rate of trait fatigue was different between groups, with MS participants showing the highest rate. Moreover, scores on functional tests and state fatigue were different between groups after the tests. Our results indicate that trait fatigue and state fatigue in individuals with SCI and MS are different with respect to able-bodied population. Both SCI and MS groups experienced more trait fatigue than control group in daily life. In addition, walking tasks produced similar levels of state fatigue between healthy people and patients with MS/SCI. However, these tests induced longer-lasting levels of state fatigue in the patients.es_ES
dc.description.sponsorshipThe authors thank Mrs. Fátima Villamayor Vega for her technical assistance, as well as financial support by the Project ICI20/00075, funded by Instituto de Salud Carlos III (ISCIII) and co-funded by the European Union and the Grant PID2020-117617-RB funded by MCIN/AEI/ 10.13039/501100011033.es_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/ISCIII/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/ICI20%2F00075/ES/EL RIMONABANT PARA LA MEJORA DE LA CAPACIDAD DE ANDAR EN LESIONADOS MEDULARESes_ES
dc.description.sponsorshipinfo:eu-repo/grantAgreement/AEI/Programa Estatal de I+D+i Orientada a los Retos de la Sociedad/PID2020-117617RB-I00/ES/SINDROME DE FATIGA POST COVID-19: ALTERACIONES DE LA EXITABILIDAD DEL SISTEMA MOTOR Y USO DEL RIMONABANT COMO TRATAMIENTO (RIMOCOVID)es_ES
dc.language.isoenges_ES
dc.publisherSpringer Naturees_ES
dc.relation.urihttps://doi.org/10.1038/s41598-024-55238-8es_ES
dc.rightsCreative Commons Attribution 4.0 International License (CC-BY 4.0)es_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.subjectNeurological disorderses_ES
dc.subjectMultiple sclerosises_ES
dc.subjectSpinal cord diseaseses_ES
dc.subjectNeurosciencees_ES
dc.subjectMotor controles_ES
dc.subjectFatiguees_ES
dc.titleFatigue insights from walking tests in spinal cord injury and multiple sclerosis individualses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessinfo:eu-repo/semantics/openAccesses_ES
UDC.journalTitleScientific Reportses_ES
UDC.volume14es_ES
UDC.issue1es_ES
UDC.startPage4761es_ES
dc.identifier.doi10.1038/s41598-024-55238-8


Ficheiros no ítem

Thumbnail
Thumbnail
Thumbnail

Este ítem aparece na(s) seguinte(s) colección(s)

Mostrar o rexistro simple do ítem